ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - January 1920

Decade

Year

Issue

February 2020, Vol 156, No. 2, Pages 111-223

In This Issue of JAMA Dermatology

Highlights

Abstract Full Text
free access
JAMA Dermatol. 2020;156(2):111. doi:10.1001/jamadermatol.2019.2999
Viewpoint

Supporting Breastfeeding Mothers During Dermatology Residency—Challenges and Best Practices

Abstract Full Text
JAMA Dermatol. 2020;156(2):117-118. doi:10.1001/jamadermatol.2019.3759

This Viewpoint reviews the challenges of breastfeeding during dermatology residency and proposes best practices for programs to support breastfeeding residents.

Editorial

Considerations in Weaning or Withdrawing Dupilumab Therapy—Nothing Is Forever

Abstract Full Text
JAMA Dermatol. 2020;156(2):119-120. doi:10.1001/jamadermatol.2019.3331

Improved Medical Photography: Key Tips for Creating Images of Lasting Value

Abstract Full Text
JAMA Dermatol. 2020;156(2):121-123. doi:10.1001/jamadermatol.2019.3849

Mucocutaneous Eruptions in Acutely Ill Pediatric Patients—Think of Mycoplasma pneumoniae (and Other Infections) First

Abstract Full Text
JAMA Dermatol. 2020;156(2):124-125. doi:10.1001/jamadermatol.2019.3589
Original Investigation

Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis: A Randomized Clinical Trial

Abstract Full Text
open access
JAMA Dermatol. 2020;156(2):131-143. doi:10.1001/jamadermatol.2019.3617

This randomized clinical trial of patients previously treated with dupilumab for atopic dermatitis assesses the efficacy of different dupilumab regimens in maintaining response after 16 weeks of initial treatment.

Frequency and Clinical Presentation of Mucocutaneous Disease Due to Mycoplasma pneumoniae Infection in Children With Community-Acquired Pneumonia

Abstract Full Text
free access
JAMA Dermatol. 2020;156(2):144-150. doi:10.1001/jamadermatol.2019.3602

This cohort study examines the frequency and clinical presentation of mucocutaneous disease due to Mycoplasma pneumoniae infection in children with community-acquired pneumonia.

Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis

Abstract Full Text
free access
JAMA Dermatol. 2020;156(2):151-157. doi:10.1001/jamadermatol.2019.3595

This cohort study examines whether soluble lectinlike oxidized low-density lipoprotein receptor-1 levels are associated with noncalcified coronary burden over time in patients with psoriasis.

Noncutaneous and Cutaneous Cancer Risk in Patients With Atopic Dermatitis: A Systematic Review and Meta-analysis

Abstract Full Text
free access
JAMA Dermatol. 2020;156(2):158-171. doi:10.1001/jamadermatol.2019.3786

This systematic review and meta-analysis investigates the risk of noncutaneous and cutaneous cancers in patients with atopic dermatitis compared with the general population without atopic dermatitis.

Global Prevalence and Incidence Estimates of Oral Lichen Planus: A Systematic Review and Meta-analysis

Abstract Full Text
free access
JAMA Dermatol. 2020;156(2):172-181. doi:10.1001/jamadermatol.2019.3797

This systematic review and meta-analysis identifies the global prevalence and incidence of oral lichen planus in the overall population and among subgroups.

Brief Report

Effect of Topical Brimonidine on Alcohol-Induced Flushing in Asian Individuals: A Randomized Clinical Trial

Abstract Full Text
has audio
JAMA Dermatol. 2020;156(2):182-185. doi:10.1001/jamadermatol.2019.3508

This randomized clinical trial determines whether brimonidine gel, 0.33%, decreases facial erythema in patients with alcohol flushing syndrome after consumption of alcohol.

Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome

Abstract Full Text
JAMA Dermatol. 2020;156(2):186-190. doi:10.1001/jamadermatol.2019.3839

This cohort study assesses the incidence of adverse events among patients with PHACE (posterior fossa malformations, hemangioma, arterial anomalies, cardiac defects, eye anomalies) syndrome receiving oral propranolol for infantile hemangioma.

Use of Epidermal Growth Factor Receptor Inhibitor Erlotinib to Treat Palmoplantar Keratoderma in Patients With Olmsted Syndrome Caused by TRPV3 Mutations

Abstract Full Text
JAMA Dermatol. 2020;156(2):191-195. doi:10.1001/jamadermatol.2019.4126

This case series investigates whether epidermal growth factor receptor transactivation with the inhibitor erlotinib could be used to treat palmoplantar keratoderma in patients with Olmsted syndrome caused by TRPV3 mutations.

Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome

Abstract Full Text
JAMA Dermatol. 2020;156(2):196-200. doi:10.1001/jamadermatol.2019.4141

This case series reports the clinical and symptomatic response following oral sirolimus and erlotinib treatment in 4 children with Olmsted syndrome.

Images in Dermatology

Cutaneous Loxoscelism

Abstract Full Text
JAMA Dermatol. 2020;156(2):203. doi:10.1001/jamadermatol.2019.3252

This case report describes a woman in her 40s who was bitten on her right lower leg by a brown spider and presented with an ulcer with central necrosis and surrounding erythema.

Malignant Atrophic Papulosis

Abstract Full Text
JAMA Dermatol. 2020;156(2):204. doi:10.1001/jamadermatol.2019.3726

This case report describes a man in his 30s who presented with ulcerations of the digestive tract and multiple papules on the trunk.

JAMA Dermatology Clinicopathological Challenge

Circular Erythematous Plaque at the Area of Median Sternotomy

Abstract Full Text
JAMA Dermatol. 2020;156(2):208-209. doi:10.1001/jamadermatol.2019.3883

A man in his 60s presented with a well-demarcated erythematous plaque at the area of median sternotomy with numerous blisters and pustules and no other symptoms. What is your diagnosis?

Facial Asymmetry With Deviated Nasal Tip

Abstract Full Text
JAMA Dermatol. 2020;156(2):210-211. doi:10.1001/jamadermatol.2019.3890

A woman in her 40s presented with a 10-year history of progressive skin thickening and subcutaneous enlargement of the right side of her nose and right cheek. What is your diagnosis?

Recurrent Blistering in an Infant

Abstract Full Text
JAMA Dermatol. 2020;156(2):212-213. doi:10.1001/jamadermatol.2019.4038

An infant boy presented with recurrent skin blisters, which were accompanied by pruritus and redness all over his body. What is your diagnosis?

Research Letter

Methotrexate for the Treatment of Recalcitrant Erosive Lichen Planus of the Vulva

Abstract Full Text
free access
JAMA Dermatol. 2020;156(2):215-217. doi:10.1001/jamadermatol.2019.4062

This retrospective medical record review evaluates the efficacy of methotrexate for treatment of recalcitrant erosive lichen planus of the vulva in women treated at a vulvar clinic.

Observation

Extracellular Crystal Deposition in Cutaneous Plasmacytosis

Abstract Full Text
JAMA Dermatol. 2020;156(2):217-218. doi:10.1001/jamadermatol.2019.3401

This case report describes extracellular crystal deposition found in the skin of a 40-year-old woman with cutaneous plasmacytosis.

Degos-Like Cutaneous Findings in an Adult Woman With NXP-2–Associated Dermatomyositis

Abstract Full Text
JAMA Dermatol. 2020;156(2):218-220. doi:10.1001/jamadermatol.2019.3940

This case report describes a woman in her 20s with progressive myalgia, proximal muscle weakness, and fever followed by facial edema, heliotrope erythema of the eyelids, and lesions resembling malignant atrophic papulosis.

Comment & Response

Implementation of Genetic Screening to Prevent Severe Cutaneous Adverse Drug Reactions Is Crucial—Rebuttal From the Devil’s Antagonist

Abstract Full Text
JAMA Dermatol. 2020;156(2):220-221. doi:10.1001/jamadermatol.2019.3950

Implementation of Genetic Screening to Prevent Severe Cutaneous Adverse Drug Reactions Is Crucial—Rebuttal From the Devil’s Antagonist—Reply

Abstract Full Text
JAMA Dermatol. 2020;156(2):221-222. doi:10.1001/jamadermatol.2019.3335

Contradictory iPledge Requirements Hinder Physician Practice and Patient Care

Abstract Full Text
JAMA Dermatol. 2020;156(2):222. doi:10.1001/jamadermatol.2019.4026

Contradictory iPledge Requirements Hinder Physician Practice and Patient Care—Reply

Abstract Full Text
JAMA Dermatol. 2020;156(2):222-223. doi:10.1001/jamadermatol.2019.3651
JAMA Dermatology Masthead

JAMA Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2020;156(2):112. doi:10.1001/jamadermatol.2019.3000
×